Related Experiment Video
Updated: Sep 21, 2025

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
A Role for PET/CT in Response Assessment of Malignant Pleural Mesothelioma
Patrick Sandach1, Robert Seifert1, Wolfgang P Fendler1
1Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.
Abstract:
Malignant pleural mesothelioma is a rare type of cancer, whose incidence, however, is increasing and will presumably continue to rise in the coming years. Key features of this disease comprise its mantle-shaped, pleura-associated, often multifocal growth, which cause diagnostic challenges. A growing number of mesotheliomas are being treated with novel immunotherapies for which no image derived general response criteria have been established. However, recent studies indicate that FDG-PET/CT could be superior for response assessment compared to CT-based criteria. This article aims at providing an overview of response assessment criteria dedicated to malignant pleural mesothelioma, such as mRECIST, iRECIST, and PERCIST. In addition, the potential future role of PET/CT in the management of malignant pleural mesothelioma will also be discussed.
Insights
Malignant pleural mesothelioma, a rare cancer, is increasing. This review discusses response assessment criteria like mRECIST, iRECIST, and PERCIST, highlighting FDG-PET/CT
Area of Science:
- Oncology
- Radiology
- Nuclear Medicine
Background:
- Malignant pleural mesothelioma is a rare cancer with increasing incidence.
- Its unique growth patterns present diagnostic challenges.
- Novel immunotherapies are emerging, necessitating standardized response assessment.
Purpose of the Study:
- To provide an overview of current response assessment criteria for malignant pleural mesothelioma.
- To discuss the role of imaging in evaluating treatment response.
- To explore the potential of FDG-PET/CT in managing this cancer.
Main Methods:
- Review of existing response assessment criteria (mRECIST, iRECIST, PERCIST).
- Discussion of CT-based criteria limitations.
- Exploration of FDG-PET/CT's utility in mesothelioma.
Main Results:
- Current general response criteria are insufficient for mesothelioma.
- FDG-PET/CT shows potential superiority over CT-based criteria for response assessment.
- Specific criteria like mRECIST, iRECIST, and PERCIST are relevant but require adaptation.
Conclusions:
- Standardized, image-derived response criteria are crucial for malignant pleural mesothelioma, especially with new therapies.
- FDG-PET/CT may offer improved accuracy in assessing treatment response.
- Further research is needed to validate and refine PET/CT-based criteria for mesothelioma management.
More Related Videos
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
09:31Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
Published on: October 2, 2015
Related Concept Videos
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Pleural Disorders: Types and Brief Description
Radiological Investigation I: X-ray and CT